News

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...
Around 20% of these centres have expanded their footprint across three or more cities, signalling a trend towards multi-city ...
The brief glimpse at pre-alpha Battlefield gameplay comes as part of a video revealing what EA calls Battlefield Labs and an accompanying call to arms for playtesters. Meanwhile, EA revealed ...
Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...
An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.
Consolidation is likely to continue, with the indices attempting to defend the previous Thursday’s low in the upcoming ...
Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art learning laboratory where high school and college students who participate ...
Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials. The candidate in question, an oral p300 ...
Citing new information from British drugmaker GSK, U.S. lawmakers are pushing forward with a probe into a pandemic-era political controversy centered around the timing of trial results for Pfizer ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company executive to investigate an allegation that clinical testing related to the ...